|
1
|
Thom T, Haase N, Rosamond W, et al;
American Heart Association Statistics Committee and Stroke
Statistics Subcommittee. Heart disease and stroke statistics - 2006
update: a report from the American Heart Association Statistics
Committee and Stroke Statistics Subcommittee. Circulation.
113:e85–e151. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Libby P: Molecular bases of the acute
coronary syndromes. Circulation. 91:2844–2850. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Foody J, Huo Y, Ji L, et al: Unique and
varied contributions of traditional CVD risk factors: A systematic
literature review of CAD risk factors in China. Clin Med Insights
Cardiol. 7:59–86. 2013.PubMed/NCBI
|
|
4
|
Okrainec K, Banerjee DK and Eisenberg MJ:
Coronary artery disease in the developing world. Am Heart J.
148:7–15. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ding H, Xu Y, Wang X, et al: 9p21 is a
shared susceptibility locus strongly for coronary artery disease
and weakly for ischemic stroke in Chinese Han population. Circ
Cardiovasc Genet. 2:338–346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiang D, Zheng D, Wang L, et al: Elevated
PLA2G7 gene promoter methylation as a gender-specific marker of
aging increases the risk of coronary heart disease in females. PLoS
One. 8:e597522013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guay SP, Brisson D, Munger J, Lamarche B,
Gaudet D and Bouchard L: ABCA1 gene promoter DNA methylation is
associated with HDL particle profile and coronary artery disease in
familial hypercholesterolemia. Epigenetics. 7:464–472. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Marenberg ME, Risch N, Berkman LF,
Floderus B and de Faire U: Genetic susceptibility to death from
coronary heart disease in a study of twins. N Engl J Med.
330:1041–1046. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zdravkovic S, Wienke A, Pedersen NL,
Marenberg ME, Yashin AI and De Faire U: Heritability of death from
coronary heart disease: a 36-year follow-up of 20,966 Swedish
twins. J Intern Med. 252:247–254. 2002.PubMed/NCBI
|
|
10
|
Murabito JM, Pencina MJ, Nam BH, et al:
Sibling cardiovascular disease as a risk factor for cardiovascular
disease in middle-aged adults. JAMA. 294:3117–3123. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Libby P, Ridker PM and Maseri A:
Inflammation and atherosclerosis. Circulation. 105:1135–1143. 2002.
View Article : Google Scholar
|
|
12
|
Lusis AJ: Atherosclerosis. Nature.
407:233–241. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
McPherson R and Davies RW: Inflammation
and coronary artery disease: insights from genetic studies. Can J
Cardiol. 28:662–666. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Duan S, Luo X and Dong C: Identification
of susceptibility modules for coronary artery disease using a
genome wide integrated network analysis. Gene. 531:347–354. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Iida A, Ozaki K, Tanaka T and Nakamura Y:
Fine-scale SNP map of an 11-kb genomic region at 22q13.1 containing
the galectin-1 gene. J Hum Genet. 50:42–45. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ozaki K, Inoue K, Sato H, et al:
Functional variation in LGALS2 confers risk of myocardial
infarction and regulates lymphotoxin-alpha secretion in
vitro. Nature. 429:72–75. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ginsburg GS, Shah SH and McCarthy JJ:
Taking cardiovascular genetic association studies to the next
level. J Am Coll Cardiol. 50:930–932. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van der Laan AM, Schirmer SH, de Vries MR,
et al: Galectin-2 expression is dependent on the rs7291467
polymorphism and acts as an inhibitor of arteriogenesis. Eur Heart
J. 33:1076–1084. 2012.PubMed/NCBI
|
|
19
|
Ikeda S, Tanaka N, Arai T, Chida K,
Muramatsu M and Sawabe M: Polymorphisms of LTA, LGALS2, and PSMA6
genes and coronary atherosclerosis: a pathological study of 1503
consecutive autopsy cases. Atherosclerosis. 221:458–460. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kimura A, Takahashi M, Choi BY, et al:
Lack of association between LTA and LGALS2 polymorphisms and
myocardial infarction in Japanese and Korean populations. Tissue
Antigens. 69:265–269. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Koch W, Hoppmann P, Michou E, et al:
Association of variants in the BAT1-NFKBIL1-LTA genomic region with
protection against myocardial infarction in Europeans. Hum Mol
Genet. 16:1821–1827. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mangino M, Braund P, Singh R, et al:
LGALS2 functional variant rs7291467 is not associated with
susceptibility to myocardial infarction in Caucasians.
Atherosclerosis. 194:112–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sedlacek K, Neureuther K, Mueller JC, et
al: Lymphotoxin-alpha and galectin-2 SNPs are not associated with
myocardial infarction in two different German populations. J Mol
Med (Berl). 85:997–1004. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang Y, Yu X, Wang L, et al: Four genetic
polymorphisms of lymphotoxin-alpha gene and cancer risk: a
systematic review and meta-analysis. PLoS One. 8:e825192013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu X, Huang Y, Li C, Yang H, Lu C and Duan
S: Positive association between lymphotoxin-alpha variation
rs909253 and cancer risk: a meta-analysis based on 36 case-control
studies. Tumour Biol. 35:1973–1983. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu X, Wang Y, Wang L, et al: Meta-analyses
of 8 polymorphisms associated with the risk of the Alzheimer’s
disease. PLoS One. 8:e731292013.
|
|
27
|
Peng P, Lian J, Huang RS, et al:
Meta-analyses of KIF6 Trp719Arg in coronary heart disease and
statin therapeutic effect. PLoS One. 7:e501262012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tang L, Wang L, Liao Q, et al: Genetic
associations with diabetes: meta-analyses of 10 candidate
polymorphisms. PLoS One. 8:e703012013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ye H, Li X, Wang L, et al: Genetic
associations with coronary heart disease: meta-analyses of 12
candidate genetic variants. Gene. 531:71–77. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Higgs ZC, Macafee DA, Braithwaite BD and
Maxwell-Armstrong CA: The Seldinger technique: 50 years on. Lancet.
366:1407–1409. 2005.PubMed/NCBI
|
|
31
|
Lewandowski M, Szwed H and Kowalik I:
Searching for the optimal strategy for the diagnosis of stable
coronary artery disease. Cost-effectiveness of the new algorithm.
Cardiol J. 14:544–551. 2007.PubMed/NCBI
|
|
32
|
Excoffier L, Laval G and Schneider S:
Arlequin (version 3.0): an integrated software package for
population genetics data analysis. Evol Bioinform Online. 1:47–50.
2007.
|
|
33
|
Kawalec P, Mikrut A, Wiśniewska N and Pilc
A: The effectiveness of tofacitinib, a novel Janus kinase
inhibitor, in the treatment of rheumatoid arthritis: a systematic
review and meta-analysis. Clin Rheumatol. 32:1415–1424. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Coory MD: Comment on: Heterogeneity in
meta-analysis should be expected and appropriately quantified. Int
J Epidemiol. 39:932–933. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Asselbergs FW, Pai JK, Rexrode KM, Hunter
DJ and Rimm EB: Effects of lymphotoxin-alpha gene and galectin-2
gene polymorphisms on inflammatory biomarkers, cellular adhesion
molecules and risk of coronary heart disease. Clin Sci (Lond).
112:291–298. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao WQ, Wang J, Xie HZ, et al:
Association between genetic variation of lymphotoxin-alpha/LGALS2
and risk of coronary arteriosclerosis disease and molecule makers.
Chin J Clin Med. 15:593–596. 2008.
|
|
37
|
Tian C: The association between coronary
artery disease and gene polymorphism in Chinese Han population.
Cardiovascular Sciences Guangzhou Medical University; WanFang Date.
pp. 952011
|
|
38
|
Ross R: Atherosclerosis is an inflammatory
disease. Am Heart J. 138:S419–S420. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Laxton R, Pearce E, Kyriakou T and Ye S:
Association of the lymphotoxin-alpha gene Thr26Asn polymorphism
with severity of coronary atherosclerosis. Genes Immun. 6:539–541.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Colhoun HM, McKeigue PM and Davey Smith G:
Problems of reporting genetic associations with complex outcomes.
Lancet. 361:865–872. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li W, Xu J, Wang X, et al: Lack of
association between lymphotoxin-alpha, galectin-2 polymorphisms and
coronary artery disease: a meta-analysis. Atherosclerosis.
208:433–436. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Panoulas VF, Nikas SN, Smith JP, et al:
Lymphotoxin 252A>G polymorphism is common and associates with
myocardial infarction in patients with rheumatoid arthritis. Ann
Rheum Dis. 67:1550–1556. 2008.
|
